Chemical Compound

Argatroban-6

CAS Registry Number 74874-10-5
Back to search Request a Quote
Argatroban-6 chemical structure
Primary Record

Argatroban-6

In stock
6,458 g
Purity
99.4 %
CAS
74874-10-5

Compound Identifiers & Properties

CAS
74874-10-5
PubChem CID
57514094
SMILES
C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N[N+](=O)[O-])NS(=O)(=O)C2=CC=CC3=C2N=CC(=C3)C
Canonical SMILES
Cc1cnc2c(S(=O)(=O)N[C@@H](CCCN=C(N)N[N+](=O)[O-])C(=O)N3CC[C@@H](C)C[C@@H]3C(=O)O)cccc2c1

Names & Synonyms

  • Argatroban-6
  • 74874-10-5
  • Argatroban Impurity G
  • 86JF2UKF4B
  • Argatroban Impurity 24
  • Argatroban Related Compound A
  • N-Nitro tetradehydroargatroban
  • UNII-86JF2UKF4B
  • RefChem:202198
  • Argatroban intermediates E
  • N-Nitro-1,2,3,4-tetradehydro Argatroban
  • (2R,4R)-1-[(2S)-5-[[IMINO(NITROAMINO)METHYL]AMINO]-2-[[(3-METHYL-8-QUINOLINYL)SULFONYL]AMINO]-1-OXOPENTYL]-4-METHYL-2-PIPERIDINECARBOXYLIC ACID
  • C23H31N7O7S
  • MFCD08458426
  • SCHEMBL28656888
  • Argatroban related compound A [USP]
  • N-Nitro tetradehydroargatroban [USP]
  • AMY21983
  • 1641AC
  • Argatroban related compound A (USP)
  • N-Nitro tetradehydroargatroban (USP)
  • AKOS016010211
  • RL04846
  • J68.568B
  • SY409954
  • ARGATROBAN RELATED COMPOUND A [USP-RS]
  • CS-0164168
  • ARGATROBAN RELATED COMPOUND A (USP-RS)
  • ARGATROBAN RELATED COMPOUND A [USP IMPURITY]
  • C16323
  • N-NITRO TETRADEHYDROARGATROBAN [USP IMPURITY]
  • A899937
  • F862503
  • ARGATROBAN RELATED COMPOUND A (USP IMPURITY)
  • N-NITRO TETRADEHYDROARGATROBAN (USP IMPURITY)
  • (2R,4R)-1-[(2S)-5-[[amino(nitramido)methylidene]amino]-2-[(3-methylquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid
  • (2R,4R)-1-(N8-Nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl)-4-methylpiperidine-2-carboxylic acid
  • (2R,4R)-4-Methyl-1-((S)-2-(3-methylquinoline-8-sulfonamido)-5-(3-nitroguanidino)pentanoyl)piperidine-2-carboxylic acid
  • 1-(N8-Nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl)-4-methylpiperidine-2-carboxylic acid, (2R,4R)-
  • 2-Piperidinecarboxylic acid, 1-[(2S)-5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-, (2R,4R)-
  • 2-PIPERIDINECARBOXYLIC ACID, 1-[5-[IMINO(NITROAMINO)METHYL]AMINO]-2-[[(3-METHYL-8-QUINOLINYL)SULFONYL]AMINO]-1-OXOPENTYL]-4-METHYL-,[2R-[1(S*), 2ALPHA, 4BETA]]-
  • [2R-[1(S*),2a,4?]-1-[5-[[iMino(nitroaMino)Methyl]aMino]-2-[[(3-Methyl-8-
  • (2r,4r)-1-((2s)-5-((imino(nitroamino)methyl)amino)-2-(((3-methyl-8-quinolinyl)sulfonyl)amino)-1-oxopentyl)-4-methyl-2-piperidinecarboxylic acid
  • (2R,4R)-1-(N8-NITRO-N2-(3-METHYLQUINOLINE-8-SULFONYL)-L-ARGINYL)-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID
  • (2R,4R)-1-[(2S)-5-[[amino(nitramido)methylene]amino]-2-[(3-methyl-8-quinolyl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid
  • (2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2- [[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid
  • (2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2- [[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity
  • (2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2- [[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)
  • (2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2- [[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity)
  • (2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity)
  • (2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylicAcid(AfatinibImpurity pound(c)
  • (2R,4R)-4-methyl-1-(N2-((3-methylquinolin-8-yl)sulfonyl)-Nw-nitro-L-arginyl)piperidine-2-carboxylic acid
  • (2R,4R)-4-methyl-1-[(2S)-2-(3-methylquinoline-8-sulfonamido)-5-(N''-nitrocarbamimidamido)pentanoyl]piperidine-2-carboxylic acid
  • (2R,4R)-4-METHYL-1-[(2S)-2-(3-METHYLQUINOLINE-8-SULFONAMIDO)-5-(N'-NITROCARBAMIMIDAMIDO)PENTANOYL]PIPERIDINE-2-CARBOXYLIC ACID
  • (2R,4R)-4-Methyl-1-[(2S)-2-[(3-methylquinolin-8-yl)sulfonylamino]-5-(3-nitroguanidino)valeryl]piperidine-2-carboxylic acid
  • (2R,4R)-4-Methyl-1-[(S)-2-(3-methylquinoline-8-sulfonamido)-5-(3-nitroguanidino)pentanoyl]piperidine-2-carboxylic Acid
  • (2R,4R)-4-Methyl-1-[N2-(3-methylquinoline-8-ylsulfonyl)-omega-nitro-L-arginyl]piperidine-2-carboxylic acid
  • [2R-[1(S*),2|A,4|A]]-1-[5-[[Imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid
  • 1-(N8-NITRO-N2-(3-METHYLQUINOLINE-8-SULFONYL)-L-ARGINYL)-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID, (2R,4R)-
  • 2-Piperidinecarboxylic acid, 1-[(2S)-5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-, (2R,4R)-; 2-Piperidinecarboxylic acid, 1-[5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-, [2R-[1(S*),2a,4ss]]-; N-Nitro-1,2,3,4-tetradehydro Argatroban; (2R,4R)-1-[N8-Nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid; N-Nitro-1,2,3,4-tetradehydroargatroban; Argatroban Compound A; Argatroban Compound G; Argatroban Compound I
  • 2-Piperidinecarboxylic acid, 1-[5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-, [2R-[1(S*),2alpha,4beta]]-
  • 74872-83-6